Modular facilities Manufacturers market Research Report by 2022, Forecast till 2035
Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035” report to its list of offerings.
berry_cristan
Key Market Insights
§ Presently, over 50 modular facility providers are engaged in the healthcare market, located across the globe
§ Currently, more than 250 modular cleanroom providers are offering controlled environments along with accessories in the healthcare domain
§ The partnership activity for modular facilities in healthcare domain has grown at a CAGR of over 30%, in the past three years, 2018-2021
§ The projected future opportunity for companies engaged in this field is expected to be well distributed across size of facility, type of industry served, type of modular construct, type of construction component, purpose of facility, scale of operation, type of product, type of expansion, type of modular construction, type of material used and key geographical regions.
§ An insightful competitiveness analysis of players involved in the modular facilities manufacturing in the healthcare domain
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS
5.1. Chapter Overview
5.2. Modular Cleanroom Providers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.4. Germfree
7.5. IPM Technologies
7.6. KeyPlants
7.7. ModuleCo Pharma
7.8. NNE
7.9. Pharmadule
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.3.1. Analysis by Type of Modular Facility
9.3.2. Analysis by Size of Modular Facility
9.3.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.3.4. Most Active Clients: Analysis by Number of Projects Received
9.3.5. Analysis by Location of Modular Facility
9.3.6. Analysis by Type of Facility and Size of Modular Facility
9.3.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Factors Influencing Modular Construction
11.3.1. Intrinsic Factors
11.3.2. Extrinsic Factors
11.4. Cost Efficiency Analysis
11.5. Time-Benefit Analysis
11.6. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Facilities Market in the Pharmaceutical / Biotechnology Sector,
2023-2035
12.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Small Facilities, 2023-203
12.4.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mid-sized Facilities, 2023-2035
12.4.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Large Facilities, 2023-2035
12.4.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Very Large Facilities, 2023-2035
12.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Facilities Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Facilities Market in the Biotechnology Industry, 2023-2035
12.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Modular Constructs, 2023-2035
12.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Equipment, 2023-2035
12.7.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Base Buildings, 2023-2035
12.7.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Process Commodities, 2023-2035
12.7.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Construction Components, 2023-2035
12.8 Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Manufacturing, 2023-2035
12.8.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Aseptic Filling, 2023-2035
12.8.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Research and Development, 2023-2035
12.8.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Purposes, 2023-2035
12.9. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Clinical Scale, 2023-2035
12.9.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Commercial Scale, 2023-2035
12.10. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Vaccines, 2023-2035
12.10.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Biosimilars, 2023-2035
12.10.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Sterile Products, 2023-2035
12.10.7. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Viral Vectors, 2023-2035
12.10.8. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Other Products, 2023-2035
12.11. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for New Facilities, 2023-2035
12.11.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Facility Expansions, 2023-2035
12.11.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Planned Expansions, 2023-2035
12.12. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Permanent Modular Construction, 2023-2035
12.13. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Steel, 2023-2035
12.13.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Wood, 2023-2035
12.13.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector for Concrete, 2023-2035
12.14. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector: Analysis by Geography, 2023 and 2035
12.14.1. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in North America, 2023-2035
12.14.2. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Europe, 2023-2035
12.14.3. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Asia, 2023-2035
12.14.4. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Middle East and North Africa, 2023-2035
12.14.5. Modular Facilities Market in the Pharmaceutical / Biotechnology Sector in Rest of the World,
2023-2035
12.15. Concluding Remaks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.2. Interview Transcript: Alan de Zayas (Modular Building Manufacturing and Construction Team)
16.3. Environmental Systems Corporation
16.3.2. Interview Transcript: Vernon Solomon (President)
16.4. Exyte
16.4.2. Interview Transcript: François Abiven (Executive Vice President Global Business Unit BLS) and Luca Mussati (Vice President Technology and Innovation)
16.5. G-Con Manufacturing
16.5.2. Interview Transcript: Maik Jornitz (Chief Executive Officer)
16.6. Modular Devices
16.6.2. Interview Transcript: Mark Koers (Executive Vice President, Sales and Marketing)
16.7. ModWave
16.7.2. Interview Transcript: Pär Almhem (President)
16.8. Subzero Engineering
16.8.2. Interview Transcript: Ward Patton (Director of Sales)
16.9. Vernick
16.9.2. Interview Transcript: Wes Temple (Director of Marketing)
16.10. Zeton
16.10.2. Interview Transcript: Sulogna Roy (Ex-Sales Manager)
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
|
Digital Therapies: The “Digital Pills” of current generation |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
